Decrease in DA uptake activity in striatal synaptosomes of <i>Ptprz-</i>KO mice. by Akihiro Fujikawa (122649)

MiR-132-3p was downregulated in TGF-<i>β</i>1 stimulated Met-5A cells and miR-132-3p mimics and miR-132-3p inhibitor transfected Met-5A cells. by Yangyang Yin (14323701)

Subjects:

Fig 5 - by Hanna Rauch (12191278)

Subjects:

S5 File - by Wenxin Ye (14392899)

Mean liver weight (g) (A), liver weight/body ratio (B), hepatic triglyceride (mg/g) (C) and hepatic steatosis quantification (% area) (D) upon completion of the treatment phase. by Elsie D. Oduor (22521785)

Hepatosomatic index % (a); Spleen somatic index % (b) in tilapia in different experimental groups. by Sinthia Kabir Mumu (17705902)

Subjects:

Lysozyme activity in different experimental groups in tilapia. by Sinthia Kabir Mumu (17705902)

Subjects:

Plasma cortisol concentration in different experimental groups in tilapia. by Sinthia Kabir Mumu (17705902)

Subjects:

Blood glucose concentrations of tilapia in different experimental groups (control, stress, prevention, and treatment) were examined. by Sinthia Kabir Mumu (17705902)

Subjects:

Fig 4 - by Sinthia Kabir Mumu (17705902)

Subjects:

Mean SARS-CoV-2 viral load log 10 between groups. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Meta-analytical results of secondary outcomes. by Maria-Sophie Brueckle (13816408)

Subjects:

Flowchart of evidence selection based on PRISMA. by Maria-Sophie Brueckle (13816408)

Subjects:

Study characteristics. by Maria-Sophie Brueckle (13816408)

Subjects:

Forest plots of primary outcomes. by Maria-Sophie Brueckle (13816408)

Subjects:

Apoptosis inhibitor prevented the decrease of IIL ESP-induced TJs expression and alleviated barrier disruption of Caco-2 monolayer. by Qi Qi Lu (17721401)

Total ISF PGE2 concentration over time (accounting for ISF probe lag time) following intramuscular administration of either 0.1 mL saline, 0.4 mg/kg meloxicam, 2.2 mg/kg flunixin o... by Emma Nixon (11772946)

Subjects:

Smoothed density histograms of simulated cumulative RCS exposures of increasing mean values. by Patrick Howlett (2612374)

Subjects:

Decreases in locomotor responses to a single METH injection in <i>Ptprz</i>-KO mice. by Akihiro Fujikawa (122649)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)